AtriCure Medical (ATRC) Value Adjusted for Debt and Cash

Official company branding of AtriCure Medical (ATRC)

The price trajectory for AtriCure, Inc. (ATRC) shown below reflects the valuation dynamics of a business protected by unique cardiology patents and stringent FDA oversight. The current Enterprise Value stands at 3035.21. AtriCure, Inc. (ATRC) maintains environmental compliance, focusing on sterility and waste disposal. However, the company's success depends on the pace of innovation amid intense pressure from global behemoths.

ATRC (AtriCure Corp) Total Company Value history from 11/23/2025 to 10/28/2026

ATRC (AtriCure, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price AtriCure Inc|ATRC - Price Target Chart
- market capitalization data:
Market Value AtriCure|ATRC - Enterprise Value
- book capitalization data:
Accounting Value per Share AtriCure|ATRC - Company Book Value|Market Cap to Net Assets Ratio atricure.com|ATRC - Company Total Assets
- debt and liquidity data:
Debt to Capital AtriCure, Inc.|ATRC - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio atricure.com|ATRC - Company Aggregate Debts|Debts to Net Assets AtriCure
General company analysis:ATRC (AtriCure Inc)
Original product of AtriCure Inc

Enterprise value combines market capitalization and net debt to determine the total acquisition price of a business. Analyzing this metric allows for an assessment of the actual financial burden and the investment attractiveness of the asset. The trend in total enterprise value reflects the market's revaluation of the company. For AtriCure, Inc. (ATRC), the stability of this figure is supported by robust logistics and strategic component reserves. Such measures minimize operational risks, ensuring value stability during an acquisition.

Competitor analysis for AtriCure, Inc.

Intuitive Surgical, Inc. - Aggregate Business Value|Total Company Value Danaher Corp (DHR)|BDX - Value Adjusted for Debt and Cash|STE (STERIS plc) - Enterprise Value|WST (westpharma.com) - Real Price to Acquire Entire Company|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|STAAR Surgical Co (STAA) - Real Price to Acquire Entire Company|NAGE (ChromaDex Corp) - Enterprise Value|Enterprise Value ZIMV|Total Company Value AngioDynamics (ANGO)|Total Company Value Cerus Corp. CERS|Real Price to Acquire Entire Company Alpha Teknova Inc|Value Adjusted for Debt and Cash Monogram Orthopedics Inc. MGRM|Enterprise Value STSS (Sharps Tech)|INFU: Company Buyout Price|Total Company Value Utah Medical Products, Inc.|KRMD (KORU Medical) - Business Value|NYXH: Total Company Value|Company Buyout Price Microbot Medical, Inc (MBOT)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)